causal
Innovation-Reward-Competition Cycle Is Distorted
The intended drug system—innovation, reward, then competition driving prices down—has been distorted into innovation, reward, more reward, and less-valuable innovation, because the large development costs (often cited as a billion dollars) apply only to genuinely new drugs (under 20% of the market) while the other 80% are recycled existing drugs that don't carry those costs and aren't the innovation society wants.
causalpending
Speaker
Robin FeldmanEvidence Quote
“those large numbers of how much it costs to develop a new drug: Those are for the new drugs. For what's probably less than 20% of the market... But, 80% of what we've got out there don't have those costs.”
Created: 6/13/2026, 12:12:41 AM
Your notes
Loading notes...